DSIP (Emideltide)
Learn what DSIP research can tell us and why the “sleep-inducing” name does not establish a sleep treatment.
Have questions? Start with a free consultation.
No deposit. Our Gilbert team will contact you within one business day.
Understand the topic before choosing a treatment
DSIP stands for delta sleep-inducing peptide and is also called emideltide. The name reflects its research history, not a guarantee that an administered product improves sleep.
Difficulty falling asleep, waking repeatedly and feeling unrefreshed are different problems. Describing the pattern helps a clinician consider appropriate evaluation and established sleep care.
This is an educational guide. It does not establish product availability or that this option is suitable for you.
How it works—and what that tells us
DSIP has been investigated in sleep-related physiology. Its role and the clinical consequences of administration are not sufficiently established to translate the name into a predictable effect on deep sleep.
A mechanism explains how something may act.
Clinical studies test benefits and harms in specific people.
Your goals and health history shape the next step.
What the evidence shows
Limited and uncertain clinical evidence
FDA reviewed emideltide literature for insomnia, narcolepsy and opioid-withdrawal nominations. The briefing does not establish a routine insomnia treatment or a validated wellness sleep program.
What it does not establish
- A sleep-stage theory does not establish better daytime function or lasting relief from insomnia.
- A wearable sleep score alone cannot diagnose a sleep disorder or demonstrate that a peptide caused improvement.
Safety questions worth discussing
- Review snoring, breathing interruptions, sedatives, alcohol and daytime sleepiness when discussing sleep.
- Do not change prescribed sleep or substance-use treatment based on peptide marketing.
Bring your goals to the conversation
You can start with what you want to understand or improve. A consultation can help you assess the research and discuss other approaches; it does not commit you to a particular treatment.
- Is my main problem falling asleep, staying asleep or feeling unrefreshed?
- Should I be evaluated for another sleep condition?
- What established behavioral or medical options fit the pattern?
Common questions about DSIP (Emideltide)
Does DSIP reliably increase deep sleep?
The name does not prove that result. The cited review leaves substantial uncertainty about effectiveness and appropriate use.
Can I assume a sleep blend is better than one ingredient?
No. A blend adds questions about the combined effects and makes it harder to identify which ingredient caused a change or side effect.
What information is useful for a sleep discussion?
Your usual sleep schedule, how long the problem has lasted, what happens during the night and how it affects your day.
Sources and further reading
- FDA compounding advisory briefing: Emideltide / DSIP-related substances
U.S. Food and Drug Administration · 2026
The cited sources describe particular products, study populations or research questions. They are not endorsements of a LifeSpann treatment. Meet our team.
Start with your goals. The consultation is free.
Free consultation · No deposit
Talk through what you want to achieve, the evidence, and the options worth considering. You do not need to choose a peptide or commit to treatment.
Our front desk will contact you within one business day to answer questions and schedule your consultation.
Prefer to call? (480) 351-7151